NCT01778803View on ClinicalTrials.gov

Phase I/Ib Study of Paclitaxel in Combination With VS-6063 in Patients With Advanced Ovarian Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

February 26, 2013

Primary Completion Date

February 23, 2015

Study Completion Date

February 23, 2015

Conditions
Ovarian Cancer
Interventions
DRUG

defactinib

DRUG

Paclitaxel

Trial Locations (3)

37203

Sarah Cannon Research Institute, Nashville

Unknown

Florida Cancer Specialists, Sarasota

University of Oklahoma, Oklahoma City

All Listed Sponsors
lead

Verastem, Inc.

INDUSTRY

NCT01778803 - Phase I/Ib Study of Paclitaxel in Combination With VS-6063 in Patients With Advanced Ovarian Cancer | Biotech Hunter | Biotech Hunter